Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen

por Chen, I-Chun, Hsiao, Li-Ping, Huang, I-Wen, Yu, Huei-Chieh, Yeh, Ling-Chun, Lin, Ching-Hung, Wei-Wu Chen, Tom, Cheng, Ann-Lii, Lu, Yen-Shen
Publicado 2017